Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers

金属有机骨架 化学 核化学 介孔材料 碘化丙啶 吸附 有机化学 生物化学 程序性细胞死亡 催化作用 细胞凋亡
作者
Xin Leng,Xiaoxv Dong,Wenping Wang,Na Sai,Chunjing Yang,Longtai You,Hongliang Huang,Xingbin Yin,Jian Ni
出处
期刊:Molecules [Multidisciplinary Digital Publishing Institute]
卷期号:23 (10): 2490-2490 被引量:76
标识
DOI:10.3390/molecules23102490
摘要

Sustained-release preparation is a hot spot in antitumor drug research, where the first task is to select suitable drug carriers. Research has revealed that carboxylic acid iron metal–organic frameworks (MOFs), constructed from iron (Fe) ions and terephthalic acid, are nontoxic and biocompatible. Due to the breathing effect, the skeleton of this mesoporous material is flexible and can reversibly adapt its pore size through drug adsorption. Therefore, we chose one kind of Fe-MOF, MIL-53(Fe), as a carrier for the anticancer drug oridonin (Ori). In this work, we report the design and synthesis of MIL-53(Fe) and explore its ability as a transport vehicle to deliver Ori. MIL-53(Fe) is characterized by scanning electron microscopy and X-ray powder diffraction. A loading capacity of 56.25 wt % was measured by high performance liquid chromatography. This carrier was safe and nontoxic (cell viability > 95.27%), depending on the results of 3-(4,5-dimethylthiazol-2-yl)--2,5-diphenyltetrazolium bromide assays, lactate dehydrogenase assays, and Annexin V-fluoresce isothiocyanate/propidium iodide double-staining assays. After loading the drug, the structure of the MIL-53(Fe) was not destroyed, and Ori was amorphous in MIL-53(Fe). Based on an analysis of the Ori release profile, results suggest that it lasts for more than seven days in vitro. The cumulative release rate of Ori at the seventh day was about 82.23% and 91.75% in phosphate buffer saline solution at 37 °C under pH 7.2 and pH 5.5, respectively. HepG2 cells were chosen to study the cytotoxicity of Ori@MIL-53(Fe), and the results show that the anticancer ratio of Ori@MIL-53(Fe) system reaches 90.62%. Thus, MIL-53 can be used as a carrier for anticancer drugs and Ori@MIL-53(Fe) is a promising sustained-release drug delivery system for the cancer therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
简单涵蕾发布了新的文献求助10
刚刚
看日落去发布了新的文献求助10
刚刚
123完成签到,获得积分10
刚刚
1秒前
1秒前
顺利毕业完成签到 ,获得积分10
1秒前
汉堡包的应助被Pan_liting采纳,获得10
1秒前
隐形曼青的应助被m1采纳,获得10
2秒前
2秒前
2秒前
英姑的应助被洁净茗茗采纳,获得10
2秒前
夜渚月明发布了新的文献求助10
3秒前
韶邑发布了新的文献求助30
3秒前
有魅力的白莲完成签到,获得积分10
3秒前
cjhhhhhhhh完成签到 ,获得积分10
4秒前
DiNg完成签到 ,获得积分20
4秒前
LC2228完成签到,获得积分10
4秒前
绵绵发布了新的文献求助10
4秒前
欢--发布了新的文献求助10
4秒前
4秒前
5秒前
冷酷以山的应助被超级无敌采纳,获得10
5秒前
5秒前
qwp关闭了qwp的文献求助
5秒前
5秒前
6秒前
Mark完成签到,获得积分10
6秒前
科研通AI6.4的应助被风筝采纳,获得10
6秒前
冷傲青柏完成签到,获得积分10
6秒前
堀沢发布了新的文献求助10
7秒前
7秒前
7秒前
李爱国的应助被优美采蓝采纳,获得10
7秒前
重要冷之发布了新的文献求助30
7秒前
华仔的应助被大hui桃采纳,获得10
7秒前
7秒前
活着完成签到,获得积分10
8秒前
wxp_bioinfo完成签到,获得积分10
8秒前
在水一方的应助被cwp采纳,获得10
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182962
求助须知:如何正确求助?哪些是违规求助? 9572244
关于积分的说明 21823803
捐赠科研通 7779552
什么是DOI,文献DOI怎么找? 3433757
关于科研通互助平台的介绍 2558000
邀请新用户注册赠送积分活动 2479926